Aller au contenu principal
Profil bibliographique

Li-Ting Kao

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées
51Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyEssential Oils and Antimicrobial ActivityLipoproteins and Cardiovascular HealthOrthopaedic implants and arthroplasty

Les publications récentes

Accès ouvert 2024 article OpenAlex

In Vivo Effect of Halicin on Methicillin-Resistant Staphylococcus aureus-Infected Caenorhabditis elegans and Its Clinical Potential

Li-Ting Kao, Tsung-Ying Yang, Wei‐Chun Hung, Wei-Te Yang et autres

Recently, the high proportion of methicillin-resistant Staphylococcus aureus infections worldwide has highlighted the urgent need for novel antibiotics to combat this crisis. The recent progress in computational techniques for use in health and medicine, especially artificial intelligence (AI), has created new and …

tw, jp (code pays fourni par la source)

5 citations Antibiotics
Accès ouvert 2022 article OpenAlex

Anabolic Effects of a Novel Simvastatin Derivative on Treating Rat Bone Defects

Tien‐Ching Lee, Huiting Chen, I‐Chun Tai, Li-Ting Kao et autres

Large bone defects may develop fracture nonunion, leading to disability and psychosocial burdens. Bone grafting with anabolic agents is a good autografting alternative. Simvastatin, as a cholesterol-lowering agent worldwide, is proven to enhance osteogenesis. Considering its dose-dependent adverse effects, we developed a …

tw (code pays fourni par la source)

3 citations Biomedicines
Accès ouvert 2021 article OpenAlex

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

Tsung-Ying Yang, Ya‐Ju Hsieh, Li-Ting Kao, Guan Hong Liu et autres

Imipenem-relebactam is a new β-lactam and β-lactamase inhibitor combination to treat carbapenem-resistant gram-negative bacteria infections. However, difference in carbapenem resistant mechanisms existed with geographic variations. To evaluate the susceptibility of imipenem-relebactam to 660 carbapenem-nonsusceptible Enterobacteriaceae isolates in Taiwan and to identify the …

tw (code pays fourni par la source)

36 citations Journal of Microbiology Immunology and Infection
Accès ouvert 2020 article OpenAlex

In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan

Tsung-Ying Yang, Ya‐Ju Hsieh, Li-Ting Kao, Guan-Hong Liu et autres

Increasing carbapenem resistance rates worldwide underscored the urgent need of novel antimicrobials. Ceftazidime–avibactam and aztreonam–avibactam combinations are developed to combat carbapenem resistance, but biological and geographic variations must be considered for antibiotic susceptibility patterns varied. Thus, we sought to assess the susceptibilities …

tw (code pays fourni par la source)

7 citations Microorganisms

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.